Eco Animal Health: Research

Following the recent announcement of plans for commercialisation of ECOVAXXIN® MS (ED report 26 February ECOVAXXIN® ‘MS commercialisation begins’), ECO Animal Health announces that the United States Department of Agriculture (USDA) has delivered a favourable safetyassessment of ECOVAXXIN® MG, the Company’s live poultry vaccine targeting Mycoplasma gallisepticum. The USDA review and acceptance of ECOVAXXIN® MG safety data represents an important step towards securing marketing authorisation for the vaccine in the United States.